Detalhe da pesquisa
1.
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
N Engl J Med
; 386(4): 340-350, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021002
2.
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
N Engl J Med
; 386(16): 1532-1546, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249272
3.
Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years.
Clin Infect Dis
; 78(2): 349-351, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758203
4.
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med
; 385(7): 585-594, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289274
5.
A case of swine influenza A(H1N2)v in England, November 2023.
Euro Surveill
; 29(3)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240057
6.
Effects of Second Dose of SARS-CoV-2 Vaccination on Household Transmission, England.
Emerg Infect Dis
; 29(1): 127-132, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529456
7.
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
Epidemiol Infect
; 151: e58, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36938806
8.
High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023.
Euro Surveill
; 28(39)2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768561
9.
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.
J Infect Dis
; 226(5): 808-811, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184201
10.
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
Lancet
; 398(10316): 2084-2092, 2021 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741816
11.
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.
Lancet
; 397(10286): 1725-1735, 2021 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901423
12.
Effectiveness of BNT162b2 and ChAdOx-1 vaccines in residents of long-term care facilities in England using a time-varying proportional hazards model.
Age Ageing
; 51(5)2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35596946
13.
Transmission dynamics of COVID-19 in household and community settings in the United Kingdom, January to March 2020.
Euro Surveill
; 27(15)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426357
14.
Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic.
Epidemiol Infect
; 149: e248, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749838
15.
An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021.
Euro Surveill
; 26(27)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240699
16.
All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England.
Euro Surveill
; 25(28)2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700669
17.
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.
Euro Surveill
; 25(32)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794447
18.
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.
N Engl J Med
; 385(25): e92, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758250
19.
Why did life expectancy in Central and Eastern Europe suddenly improve in the 1990s? An analysis by cause of death.
Scand J Public Health
; 43(8): 796-801, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26261189
20.
The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis.
Hum Vaccin Immunother
; 20(1): 2311969, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299507